MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹4.56 Cr | ₹3.25 Cr | ₹1.86 Cr | ₹2.11 Cr | ₹1.48 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹4.56 Cr |
Mar2023 | ₹3.25 Cr |
Mar2022 | ₹1.86 Cr |
Mar2021 | ₹2.11 Cr |
Mar2020 | ₹1.48 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹4.56 Cr | 40.19 | |
Mar2023 | ₹3.25 Cr | 75.22 | |
Mar2022 | ₹1.86 Cr | -12.08 | |
Mar2021 | ₹2.11 Cr | 43.12 | |
Mar2020 | ₹1.48 Cr | - |
Compare Long Term Provisions of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,438.8 Cr | -4.7% | -14% | 64.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -4.7% |
-14% |
64.1% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses